Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
R. Eric Davis, a medical student at the University of Arkansas for Medical Sciences, has research interests focused on cancer biology and therapeutics. His recent work includes a 2024 publication investigating the effects of CB-839 on lung tumor cells, exploring its potential to induce reversible dormancy. Davis has also contributed to studies examining strategies to overcome resistance to venetoclax in aggressive B-cell lymphomas, with several publications in 2023 detailing supplementary figures and tables related to this research.
His scholarship metrics include an h-index of 1, with 15 total publications and 6 total citations. Davis collaborates with researchers at his institution, including Ruud P.M. Dings, Eric R. Siegel, Gunnar Boysen, and Azemat Jamshidi‐Parsian, with whom he has shared publications. His work is characterized by an active research presence, with his most recent publication in 2024.
Metrics
- h-index: 1
- Publications: 15
- Citations: 8
Selected Publications
-
CB-839 induces reversible dormancy in lung tumor-cells (2024)
Collaboration Network
Top Collaborators
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
Similar Researchers
Based on overlapping research topics